
Abitate 250mg Tablet
Marketer
RPG Life Sciences Ltd
Salt Composition
Abiraterone Acetate (250mg)
Overview Abitate 250mg Tablet
Prostacept 250mg tablets are indicated for prostate cancer management. Their use may extend to other conditions as directed by a physician, potentially within a combination chemotherapy regimen. Prostacept 250mg should be administered with food to mitigate potential adverse effects; taking it on an empty stomach is not recommended. Dosage and frequency are determined individually by your doctor, dependent on your specific condition and subject to adjustment. Strict adherence to the prescribed regimen is crucial, as deviations can lead to severe consequences. Therapeutic benefits may take weeks or months to manifest; discontinue use only under your doctor's instructions. Common side effects include nausea, hypokalemia, swelling, leukopenia, and tiredness. Report any concerning symptoms to your doctor; mitigation strategies may be available. Less frequent side effects, suggestive of liver dysfunction, include jaundice, anorexia, dyspnea, dark urine, and vomiting. Your physician may monitor liver function, blood pressure, and potassium levels. Prior to commencing treatment, disclose any pre-existing conditions such as hypertension, cardiac issues, hepatic or renal impairment, or current medication use, particularly anti-infectives. Significant drug interactions are possible; inform your doctor of all medications you are taking. This medication is contraindicated during pregnancy and lactation due to potential fetal harm. Reliable contraception is essential for both partners throughout the treatment period. Regular blood glucose monitoring may be required during therapy.
Uses of Abitate 250mg Tablet
Malignancy of the prostate gland
Major Benefits of Abitate 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 250mg Abitate tablet whole; do not chew, crush, or break it. Administer on an empty stomach.
Common Side effects of Abitate 250mg Tablet:
- Edema (swelling)
- Vomiting
- Decreased potassium level in blood
- Fatigue
- Anemia (low number of red blood cells)
- Urinary tract infection
- Diarrhea
- High blood pressure
- Cough
- Joint swelling
How to use Abitate 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 250mg Abitate tablet whole; do not chew, crush, or break it. Administer on an empty stomach.
How Abitate 250mg Tablet works:
Abitate 250mg tablets are used in cancer treatment. They function by suppressing the body's production of androgens, the male hormones. This effect is achieved through the inhibition of CYP17, a key enzyme in androgen synthesis. Consequently, the growth of prostate cancer is retarded.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Abitate 250mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Using Abitate 250mg tablets during pregnancy is strongly discouraged due to substantial risks. Pregnant women should consult their physician; research in animal and human studies indicates considerable harm to the unborn child.
Breast feedingUNSAFE
Lactation and the use of Abitate 250mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Abitate 250mg Tablets.
KidneyCAUTION
The use of Abitate 250mg tablets requires careful consideration in individuals with advanced kidney impairment. Dosage modification of Abitate 250mg tablets might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Abitate 250mg tablets cautiously. Dosage modification for Abitate 250mg tablets may be necessary; physician consultation is advised.
What if you forget to take Abitate 250mg Tablet :
Omit any missed dose of Abitate 250mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Abitate 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Androstenedione derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
